Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Net Cash Flow (2020 - 2025)

GoHealth's Net Cash Flow history spans 6 years, with the latest figure at -$3.6 million for Q3 2025.

  • For Q3 2025, Net Cash Flow fell 116.85% year-over-year to -$3.6 million; the TTM value through Sep 2025 reached -$3.6 million, down 138.81%, while the annual FY2024 figure was -$49.8 million, 167.07% down from the prior year.
  • Net Cash Flow for Q3 2025 was -$3.6 million at GoHealth, down from $13.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $139.1 million in Q3 2022 and bottomed at -$199.0 million in Q4 2022.
  • The 5-year median for Net Cash Flow is $880000.0 (2023), against an average of -$5.9 million.
  • The largest annual shift saw Net Cash Flow crashed 25644.63% in 2022 before it skyrocketed 2329.89% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$773000.0 in 2021, then plummeted by 25644.63% to -$199.0 million in 2022, then surged by 132.45% to $64.6 million in 2023, then plummeted by 91.61% to $5.4 million in 2024, then tumbled by 166.49% to -$3.6 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Net Cash Flow are -$3.6 million (Q3 2025), $13.2 million (Q2 2025), and -$18.6 million (Q1 2025).